Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_assertion type Assertion NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_head.
- NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_assertion description "[TLR4 signaling may contribute to melanoma progression, and caution should be exercised when using TLR4 ligands as adjuvant therapy for cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_provenance.
- NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_assertion evidence source_evidence_literature NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_provenance.
- NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_assertion SIO_000772 25175033 NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_provenance.
- NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_assertion wasDerivedFrom befree-2016 NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_provenance.
- NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_assertion wasGeneratedBy ECO_0000203 NP1215583.RAT2Mm5dzH3QWnBHEEpHYSJg42Oh16Gl29-LYqzS_Q3Qs130_provenance.